Dallas Formulations Private Limited

Dallas Formulations Private Limited - pharma in Ujjain, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24233MP2000PTC014476 Incorporated 24 November 2000 ROC Gwalior HQ Ujjain, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹10.53 Cr
▲ 47% YoY
Net profit · FY 2025
₹17.31 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹85.56 Lakh
EBITDA margin 8.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹39.09 Lakh
Issued & subscribed
Open charges
₹2.66 Cr
Satisfied ₹5.24 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
20
Provident fund records

About Dallas Formulations Private Limited

Data last updated:

Dallas Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2000PTC014476. Its GSTIN is 02AACCD5000G1ZJ (Himachal Pradesh).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹39.09 Lakh. It was formerly known as Chirayu Ayurveda Private Limited. It is led by directors Mukesh Kumar (Whole-Time Director) and Rajesh Gupta.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 220 Block – C 2nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.53 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹17.31 Lakh (net margin 1.6%) and EBITDA of ₹85.56 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.

The company has about 20 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Dallas Formulations. As per MCA filings, the company has open charges of ₹2.66 Cr and satisfied charges of ₹5.24 Cr on record. Court records list 9 cases involving the company, including 3 filed by the company and 6 filed against it; 1 case is pending.

Dallas Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0009118). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dallaspharma.com.

Company details

CIN U24233MP2000PTC014476
Registration Number 014476
Incorporation Date 24 November 2000
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0009118

Recognitions & Rankings of Dallas Formulations

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-HP-11-0009118

Contact details

Dallas Formulations Private Limited's registered office is in Ujjain, Madhya Pradesh. Its website is dallaspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    220 Block – C 2nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dallas Formulations Private Limited, buy the company report.

Comprehensive company report
Dallas Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dallas Formulations operates one associated brand: Dallas Formulations. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical tablets, capsules, and injectables for health markets.dallaspharma.com

Business activity

The main business activity of Dallas Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dallas Formulations Private Limited, buy the company report.

Financials of Dallas Formulations Private Limited

FY 2024 filings available

Dallas Formulations Private Limited reported revenue of ₹10.53 Cr (up 47% YoY) for FY 2025.

Revenue · FY 2025
₹10.53 Cr ▲ 47%
Net profit · FY 2025
₹17.31 Lakh margin 1.6%
EBITDA · FY 2025
₹85.56 Lakh margin 8.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 5%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 7%
5 years · compounded
▼ 1%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 47% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹85.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹17.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.1%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dallas Formulations Private Limited, buy the company report.

Board of directors of Dallas Formulations Private Limited

Dallas Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajesh GuptaDirector16 Jan 200620 Years 10 MonthsCurrent
Mukesh KumarWhole-Time Director21 Jul 20224 Years 3 MonthsCurrent

Peer comparison

Dallas Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pharmtech Solutions Private Limited₹10.59 Cr (FY 2019)397.0%Hyderabad, Telangana, India
Salus Laboratories Private Limited₹10.59 Cr (FY 2024)45.0%Madhura Nagar, Telangana, India
Biowin Healthcare Limited₹10.57 Cr (FY 2025)-3.0%Ahmedabad, Gujarat, India
Dallas Formulations Private Limitedthis company₹10.53 Cr (FY 2025)₹17.31 Lakh1.6%47.0%20Ujjain, Madhya Pradesh, India
Astron Pharmaceuticals Private Limited₹10.49 Cr (FY 2025)15.0%New Delhi, Delhi, India
Sri Mallikarjuna Chemicals Private Limited₹10.49 Cr (FY 2024)25.0%Hyderabad, Telangana, India
Biomiicron Pharma India Private Limited₹10.49 Cr (FY 2024)-1.0%Chennai, Tamil Nadu, India
Wizcure Pharmaa Private Limited₹10.47 Cr (FY 2024)17.0%Alwar, Rajasthan, India

To see the full peer comparison of Dallas Formulations Private Limited, buy the company report.

Auditor

Dallas Formulations Private Limited is audited by V.K. Ladha & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
V.K. Ladha & AssociatesFY 2024002301C

Shareholding

The shareholding of Dallas Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dallas Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.66 Cr
Satisfied charges
₹5.24 Cr
Breakdown by lending institutions
State Bank of India₹2.66 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Nov 200610030257State Bank of India₹2.66 CrOpen
28 Nov 201310466437Ing Vysya Bank Limited₹1.75 CrSatisfied
17 Aug 201110302287Dir. of Industries with Parri Passu Sbi Baddi₹1.29 CrSatisfied
29 Apr 200610016367State Bank of India₹2.2 CrSatisfied

To see the full charge records of Dallas Formulations Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dallas Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Dallas Formulations Private Limited has a workforce of 20 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
20
Active EPFO establishments
1
Employee growth
-31%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2720
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Dallas Formulations Private Limited, buy the company report.

GST

Dallas Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AACCD5000G1ZJHimachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Dallas Formulations Private Limited, buy the company report.

Recent activity

Dallas Formulations Private Limited has 5 board changes on record since 2006: 2 appointments and 3 cessations. The latest: Mukesh Kumar was appointed as Whole-Time Director on 21 Jul 2022.

Charges
A charge registered on 17 Aug 2011 via Charge ID 10302287 with Dir. Of Industries With Parri Passu Sbi Baddi was fully satisfied on 22 Apr 2025.
AGM
Dallas Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dallas Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Charges
A charge with State Bank Of India of Rs. 266.00 Lakh registered on 11 Nov 2006 with Charge ID 10030257 was modified on 15 May 2023.
Appointed
Mukesh Kumar was appointed as Whole-Time Director.
Ceased
Anil Kumar ceased to be Additional Director.
Ceased
Nandkishore Maheshwari ceased to be Director.
Ceased
Jambukumar Jain ceased to be Director.
Charges
A charge registered on 28 Nov 2013 via Charge ID 10466437 with Ing Vysya Bank Limited was fully satisfied on 29 Oct 2014.
Charges
A charge with Ing Vysya Bank Limited amounted to Rs. 175.00 Lakh with Charge ID 10466437 was registered on 28 Nov 2013.
Charges
A charge registered on 29 Apr 2006 via Charge ID 10016367 with State Bank Of India was fully satisfied on 04 Jul 2013.
Charges
A charge with Dir. Of Industries With Parri Passu Sbi Baddi amounted to Rs. 129.07 Lakh with Charge ID 10302287 was registered on 17 Aug 2011.

5 earlier events are in the company report.

Frequently asked questions

Dallas Formulations is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2000 (26+ years old) and is registered under CIN U24233MP2000PTC014476.

Dallas Formulations has 2 current directors:

The latest financial statements of Dallas Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Dallas Formulations is 02AACCD5000G1ZJ, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Dallas Formulations is U24233MP2000PTC014476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dallas Formulations has 9 court cases on record: 3 filed by the company and 6 filed against it. 1 is pending. Most are in the high courts.

Dallas Formulations was incorporated on 24 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Dallas Formulations by revenue are Pharmtech Solutions Private Limited, Salus Laboratories Private Limited, Biowin Healthcare Limited, Astron Pharmaceuticals Private Limited, Sri Mallikarjuna Chemicals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mukesh Kumar was appointed as Whole-Time Director on 21 Jul 2022. Anil Kumar ceased to be Additional Director on 30 Sep 2019. Nandkishore Maheshwari ceased to be Director on 04 Oct 2018. Dallas Formulations has 5 board changes on record in total.

Yes, Dallas Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0009118).

Dallas Formulations can be reached through the website dallaspharma.com. Its registered office is in Ujjain, Madhya Pradesh, India.